New MS drug trial aims to control relapses and slow disability
NCT ID NCT07483450
Summary
This study is testing the effectiveness and safety of the drug ocrelizumab in Chinese adults with two forms of multiple sclerosis (MS). The goal is to see if the treatment can reduce relapses, slow disease progression, and improve quality of life. Participants will receive the drug and be monitored for one year to track their symptoms, brain scans, and overall health.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
1st Affiliated Hospital of Shanxi Medical University
RECRUITINGTaiyuan, 030000, China
-
Beijing Hospital of Ministry of Health
RECRUITINGBeijing, 100730, China
-
Inner Mongolia Autonomous Region People's Hospital
RECRUITINGHohhot, 010011, China
-
Lanzhou University Second Hospital
RECRUITINGLanzhou, 730030, China
-
Peking Union Medical College Hospital
RECRUITINGBeijing, 100032, China
-
Peking University First Hospital
RECRUITINGBeijing, 100034, China
-
The First Affiliated Hospital of College of Medicine, Zhejiang University
RECRUITINGHangzhou, 310003, China
-
The First Affiliated Hospital of Nanchang University
RECRUITINGNanchang, Jiangxi, 330209, China
-
The First Affiliated Hospital of Sun Yat-sen University
RECRUITINGGuangzhou, 510080, China
-
The First Affiliated Hospital, Chongqing Medical University
RECRUITINGChongqing, 400016, China
-
The First Hospital of China Medical University
RECRUITINGShenyang, DUMMY_VALUE, China
-
The Second Hospital of Hebei Medical University
RECRUITINGShijiazhuang, 050000, China
-
The Third Affiliated Hospital of Sun Yat-Sen University
RECRUITINGGuangzhou, 510630, China
-
Tongji Hospital Tongji Medical College Huazhong University of Science and Technology
RECRUITINGWuhan, 430030, China
-
West China Hospital of Sichuan University
RECRUITINGChengdu, 610041, China
-
Xiangya Hospital Central South University
RECRUITINGChangsha, 410008, China
-
Xinjiang People Hospital
RECRUITINGÜrümqi, 830000, China
Conditions
Explore the condition pages connected to this study.